<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01353287</url>
  </required_header>
  <id_info>
    <org_study_id>VERITAS</org_study_id>
    <nct_id>NCT01353287</nct_id>
  </id_info>
  <brief_title>Transcatheter Aortic Valve Intervention-Live Transmission</brief_title>
  <acronym>VERITAS</acronym>
  <official_title>Transcatheter Aortic Valve Intervention-Live Transmission (VERITAS)Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medstar Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Food and Drug Administration (FDA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Medstar Health Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this clinical trial is to evaluate safety of patients who underwent&#xD;
      Transcatheter Aortic Valve Intervention (TAVI) during a live case or video-taped transmission&#xD;
      as compared to those without procedure transmission.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A series of sites from outside the US, where the Edwards-Sapien and CoreValve devices are&#xD;
      approved for commercial sale and implantation, will be recruited to retrospectively identify&#xD;
      and extract in-hospital data of a patient who underwent TAVI during a live or video-taped&#xD;
      procedure and a matched patient who underwent TAVI without transmission of the procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major complication defined as in hospital death, stroke, tamponade, valve embolization, coronary obstruction, renal failure requiring dialysis, and the need for a pacemaker.</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">110</enrollment>
  <condition>Aortic Valve Disorder</condition>
  <arm_group>
    <arm_group_label>TAVI live case or video-taped transmission</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>TAVI without transmission</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients, male or female, over 18 years of age who have either undergone live case or&#xD;
        video-taped transmission of TAVI procedure (Case), or have undergone the procedure without&#xD;
        procedure transmission(Control).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Cases Inclusion Criteria:&#xD;
&#xD;
          -  Subjects &gt; 18 years of age, male or female&#xD;
&#xD;
          -  Subject had live case or video-taped transmission of TAVI procedure with:&#xD;
&#xD;
        Edwards-Sapien transfemoral approach, Edwards-Sapien transapical approach, or CoreValve&#xD;
        transfemoral approach&#xD;
&#xD;
        Controls Inclusion Criteria:&#xD;
&#xD;
          -  Subjects &gt; 18 years of age, male or female&#xD;
&#xD;
          -  Subject underwent TAVI without procedure transmission and had:&#xD;
&#xD;
        Edwards-Sapien transfemoral approach, Edwards-Sapien transapical approach, or CoreValve&#xD;
        transfemoral approach&#xD;
&#xD;
          -  Subjects will be matched to Cases upon the following:&#xD;
&#xD;
          -  STS SCORE +/- 2points&#xD;
&#xD;
          -  Date of TAVI procedure +/- 4weeks&#xD;
&#xD;
          -  The first attending for the TAVI procedure&#xD;
&#xD;
          -  Access site for TAVI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ron Waksman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington Hospital Center, Washington, DC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVasculares Centrum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guys and St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <study_first_submitted>May 11, 2011</study_first_submitted>
  <study_first_submitted_qc>May 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2011</study_first_posted>
  <last_update_submitted>July 30, 2013</last_update_submitted>
  <last_update_submitted_qc>July 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transcatheter Aortic Valve Intervention (TAVI)</keyword>
  <keyword>Live case transmission</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

